Temat: "Ovarian" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Prevalence of Pathogenic Germline BRCA1/2 Variants and Their Association with Clinical Characteristics in Patients with Epithelial Ovarian Cancer in a Rural Area of Japan.
Autorzy :: Abe A; Department of Gynecology, Cancer Institute Hospital of JCFR, Tokyo 135-8550, Japan.; Department of Obstetrics and Gynecology, Tokushima University, Tokushima 770-8503, Japan.
Imoto I; Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Tange S; Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Nishimura M; Department of Obstetrics and Gynecology, Tokushima University, Tokushima 770-8503, Japan.
Iwasa T; Department of Obstetrics and Gynecology, Tokushima University, Tokushima 770-8503, Japan.; Pokaż więcej
Źródło :: Genes [Genes (Basel)] 2022 Jun 18; Vol. 13 (6). Date of Electronic Publication: 2022 Jun 18.
Typ publikacji :: Journal Article
MeSH Terms :: Hereditary Breast and Ovarian Cancer Syndrome*
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/genetics
BRCA1 Protein/genetics ; Carcinoma, Ovarian Epithelial/diagnosis ; Carcinoma, Ovarian Epithelial/epidemiology ; Carcinoma, Ovarian Epithelial/genetics ; Female ; Germ Cells ; Germ-Line Mutation ; Humans ; Japan/epidemiology ; Prevalence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Diagnostic failures in ovarian torsion during childhood: The effect of ovarian cyst size on the diagnostic accuracy of Doppler ultrasonography.
Autorzy :: Ulusoy O; Department of Pediatric Surgery, Dokuz Eylul University, Izmir, Turkey.
Karakuş OZ; Department of Pediatric Surgery, Dokuz Eylul University, Izmir, Turkey.
Ateş O; Department of Pediatric Surgery, Dokuz Eylul University, Izmir, Turkey.; Division of Pediatric Urology, Dokuz Eylul University, Izmir, Turkey.
Hakgüder G; Department of Pediatric Surgery, Dokuz Eylul University, Izmir, Turkey.; Division of Pediatric Urology, Dokuz Eylul University, Izmir, Turkey.
Olguner M; Department of Pediatric Surgery, Dokuz Eylul University, Izmir, Turkey.; Division of Pediatric Urology, Dokuz Eylul University, Izmir, Turkey.
Akgür FM; Department of Pediatric Surgery, Dokuz Eylul University, Izmir, Turkey.; Division of Pediatric Urology, Dokuz Eylul University, Izmir, Turkey.; Pokaż więcej
Źródło :: Journal of clinical ultrasound : JCU [J Clin Ultrasound] 2022 Jun; Vol. 50 (5), pp. 660-665. Date of Electronic Publication: 2022 Mar 02.
Typ publikacji :: Journal Article
MeSH Terms :: Ovarian Cysts*/complications
Ovarian Cysts*/diagnostic imaging
Ovarian Diseases*/diagnostic imaging
Female ; Humans ; Ovarian Torsion ; Torsion Abnormality/diagnostic imaging ; Ultrasonography ; Ultrasonography, Doppler
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Autorzy :: Marinelli LM; Department of Pathology and Area Laboratory Services, San Antonio Military Medical Center, San Antonio, TX, United States of America.
Kisiel JB; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Slettedahl SW; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America.
Mahoney DW; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America.
Lemens MA; Obstetrics and Gynecology, Division of Gynecologic Oncology Surgery, Mayo Clinic, Rochester, MN, United States of America.
Shridhar V; Department of Laboratory Medicine and Pathology, Experimental Pathology, Mayo Clinic, Rochester, MN, United States of America.
Taylor WR; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Staub JK; Department of Laboratory Medicine and Pathology, Experimental Pathology, Mayo Clinic, Rochester, MN, United States of America.
Cao X; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Foote PH; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Burger KN; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America.
Berger CK; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
O'Connell MC; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Doering KA; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Giakoumopoulos M; Exact Sciences, Madison, WI, United States of America.
Berg H; Exact Sciences, Madison, WI, United States of America.
Volkmann C; Exact Sciences, Madison, WI, United States of America.
Solsrud A; Exact Sciences, Madison, WI, United States of America.
Allawi HT; Exact Sciences, Madison, WI, United States of America.
Kaiser M; Exact Sciences, Madison, WI, United States of America.
Vaccaro AM; Exact Sciences, Madison, WI, United States of America.
Albright Crawford C; Exact Sciences, Madison, WI, United States of America.
Moehlenkamp C; Exact Sciences, Madison, WI, United States of America.
Shea G; Exact Sciences, Madison, WI, United States of America.
Deist MS; Exact Sciences, Madison, WI, United States of America.
Schoolmeester JK; Department of Laboratory Medicine and Pathology, Anatomic Pathology, Mayo Clinic, Rochester, MN, United States of America.
Kerr SE; Hospital Pathology Associates, Minneapolis, MN, United States of America.
Sherman ME; Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, United States of America.
Bakkum-Gamez JN; Obstetrics and Gynecology, Division of Gynecologic Oncology Surgery, Mayo Clinic, Rochester, MN, United States of America. Electronic address: .; Pokaż więcej
Źródło :: Gynecologic oncology [Gynecol Oncol] 2022 Jun; Vol. 165 (3), pp. 568-576. Date of Electronic Publication: 2022 Mar 31.
Typ publikacji :: Journal Article
MeSH Terms :: DNA Methylation*
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/genetics
Biomarkers, Tumor/genetics ; CELF Proteins/genetics ; Carcinoma, Ovarian Epithelial/diagnosis ; Carcinoma, Ovarian Epithelial/genetics ; Feasibility Studies ; Female ; Genetic Markers ; Humans ; Nerve Tissue Proteins/genetics ; Transaminases/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
Autorzy :: O'Cearbhaill RE; GOG Foundation and the Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: .
Pérez-Fidalgo JA; Department of Medical Oncology, INCLIVA University Hospital of Valencia, CIBERONC, Valencia, Spain.
Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ, USA.
Tusquets I; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.
McCormick C; GOG and Legacy Medical Group Gynecologic Oncology, Portland, OR, USA.
Fuentes J; Servicio de Oncologia, Hospital de Valme, Sevilla, Spain.
Moore RG; Division of Gynecologic Oncology, Wilmot Cancer Institute, Department of Obstetrics and Gynecology, University of Rochester, Rochester, NY, USA.
Vulsteke C; BGOG and the Department of Medical Oncology and Hematology, AZ Maria Middelares, Ghent, Belgium, and the Department of Molecular Imaging, Pathology, Radiotherapy, and Oncology, Center for Oncological Research, Antwerp University, Antwerp, Belgium.
Shahin MS; Abington Hospital-Jefferson Health, Sidney Kimmel Cancer Center of Thomas Jefferson University, Willow Grove, PA, USA.
Forget F; Department of Medical Oncology, Libramont Hospital, Libramont, Belgium.
Bradley WH; GOG and the Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.
Hietanen S; Department of Obstetrics and Gynecology, Turku University Hospital and FICAN West, Turku, Finland.
O'Malley DM; Ohio State University, James Comprehensive Cancer Center, Columbus, OH, USA.
Dørum A; Gynecologic Oncology, Oslo University Hospital, The Norwegian Radiumhospital, Oslo, Norway.
Slomovitz BM; Broward Health, Mount Sinai Medical Center, Florida International University Wertheim College of Medicine, Miami Beach, FL, USA.
Baumann K; Arbeitsgemeinschaft Gynäkologische Onkologie and the Department of Gynecology and Obstetrics, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany.
Selle F; GINECO and Groupe Hospitalier Diaconesses-Croix Saint Simon, Paris, France.
Calvert PM; Cancer Trials Ireland, Dublin, Ireland.
Artioli G; Ulss2 Oncologia Medica Marca Trevigiana, Treviso, Italy.
Levy T; Department of Obstetrics and Gynecology, Wolfson Medical Center, Sackler School of Medicine, Tel Aviv University, Holon, Israel.
Kumar A; Department of Medical Oncology, BC Cancer, Fraser Valley Cancer Centre, Surrey, BC, Canada.
Malinowska IA; GlaxoSmithKline, Waltham, MA, USA.
Li Y; GlaxoSmithKline, Waltham, MA, USA.
Gupta D; GlaxoSmithKline, Waltham, MA, USA.
González-Martín A; Grupo Español de Investigación en Cáncer de Ovario (GEICO), the Medical Oncology Department, Clínica Universidad de Navarra, and Program in Solid Tumors, Center for Applied Medical Research (CIMA), Madrid, Spain.; Pokaż więcej
Źródło :: Gynecologic oncology [Gynecol Oncol] 2022 Jul; Vol. 166 (1), pp. 36-43. Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Clinical Trial, Phase III; Journal Article
MeSH Terms :: Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/surgery
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/surgery ; Chemotherapy, Adjuvant ; Cytoreduction Surgical Procedures ; Female ; Humans ; Indazoles/therapeutic use ; Neoadjuvant Therapy ; Neoplasm Staging ; Neoplasm, Residual ; Piperidines
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.
Autorzy :: Schettino C; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, 'Fondazione Giovanni Pascale', Naples, Italy.
Musacchio L; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, Rome, Italy.
Bartoletti M; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Chiodini P; Department of Mental Health and Public Medicine, Section of Statistics, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Arenare L; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, 'Fondazione Giovanni Pascale', Naples, Italy.
Baldassarre G; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Califano D; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy.
Capoluongo E; Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli Federico II, Naples, Italy.; Azienda Ospedaliera per L'Emergenza, Cannizzaro, Catania, Italy.
Costi MP; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
D'Incalci M; Laboratory of Molecular Pharmacology, Group of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Marchini S; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Mezzanzanica D; Molecular Therapies Unit, Department of Research, Istituto Nazionale dei Tumori IRCCS, Milan, Italy.
Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori 'Fondazione Giovanni Pascale', Naples, Florida, USA.
Scala S; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy.
Greggi S; Gynecologic Oncology Surgery, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
Perrone F; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, 'Fondazione Giovanni Pascale', Naples, Italy.
Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS 'Fondazione Giovanni Pascale', Naples, Italy, 80131 .; Pokaż więcej
Źródło :: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2022 Jun 06; Vol. 32 (6), pp. 799-803. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Antineoplastic Agents*/therapeutic use
Mangifera*
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/surgery
Adenosine Diphosphate/therapeutic use ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/surgery ; Cytoreduction Surgical Procedures ; Female ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/surgery ; Phthalazines ; Piperazines ; Platinum/therapeutic use ; Poly(ADP-ribose) Polymerase Inhibitors ; Ribose/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Pamiparib for germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer.
Autorzy :: Skrzypczyk-Ostaszewicz A; Military Institute of Medicine, Department of Oncology, Warsaw, Poland. .; Pokaż więcej
Źródło :: Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2022 Jun; Vol. 58 (6), pp. 299-309.
Typ publikacji :: Journal Article
MeSH Terms :: Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Prostatic Neoplasms*/drug therapy
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/pathology ; Fallopian Tubes/pathology ; Female ; Fluorenes ; Germ Cells/pathology ; Humans ; Male ; Mutation ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects ; Tumor Suppressor Proteins/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Scream Sound-induced Chronic Psychological Stress Results in Diminished Ovarian Reserve in Adult Female Rat.
Autorzy :: Xi W; The Second Affiliation Hospital of Xi'an Jiao Tong University, Xi'an City, China.
Mao H; The Second Affiliation Hospital of Xi'an Jiao Tong University, Xi'an City, China.
Cui Z; The First Affiliation Hospital of Xi'an Jiao Tong University, Xi'an City, China.
Yao H; The Second Affiliation Hospital of Xi'an Jiao Tong University, Xi'an City, China.
Shi R; The Second Affiliation Hospital of Xi'an Jiao Tong University, Xi'an City, China.
Gao Y; The Second Affiliation Hospital of Xi'an Jiao Tong University, Xi'an City, China.; Pokaż więcej
Źródło :: Endocrinology [Endocrinology] 2022 Jun 01; Vol. 163 (6).
Typ publikacji :: Journal Article
MeSH Terms :: Ovarian Diseases*/metabolism
Ovarian Reserve*/physiology
Stress, Psychological*/pathology
Animals ; Anti-Mullerian Hormone/metabolism ; Female ; Ovarian Follicle/metabolism ; Rats
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.
Autorzy :: Lof P; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, the Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: .
Retèl VP; Department of Health Technology Assessment, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands.
Algera MD; Dutch Institute for Clinical Auditing (DICA), Scientific Bureau, Leiden, the Netherlands; Department of Obstetrics and Gynecology, Maastricht University Medical Center (MUMC), Maastricht, the Netherlands.
van Gent MDJM; Center for Gynecologic Oncology Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Gaarenstroom KN; Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
van Driel WJ; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Pokaż więcej
Źródło :: Gynecologic oncology [Gynecol Oncol] 2022 Jun; Vol. 165 (3), pp. 459-465. Date of Electronic Publication: 2022 Apr 09.
Typ publikacji :: Journal Article
MeSH Terms :: Laparoscopy*/methods
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/surgery
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/therapy ; Cytoreduction Surgical Procedures/adverse effects ; Female ; Humans ; Hyperthermic Intraperitoneal Chemotherapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: The impact of secondary cytoreductive surgery in platinum sensitive recurrent ovarian cancer treated with upfront neoadjuvant chemotherapy and interval debulking surgery.
Autorzy :: Bizzarri N; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Marchetti C; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Conte C; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Loverro M; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Giudice MT; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Quagliozzi L; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Distefano M; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Chiantera V; Department of Gynecologic Oncology, ARNAS Ospedali Civico Di Cristina Benfratelli, University of Palermo, Palermo, Italy.
Scambia G; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: .
Fagotti A; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.; Pokaż więcej
Źródło :: Gynecologic oncology [Gynecol Oncol] 2022 Jun; Vol. 165 (3), pp. 453-458. Date of Electronic Publication: 2022 Apr 06.
Typ publikacji :: Journal Article
MeSH Terms :: Cytoreduction Surgical Procedures*
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/surgery
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/surgery ; Chemotherapy, Adjuvant ; Cohort Studies ; Female ; Humans ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery.
Autorzy :: Lim H; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
In Shim J; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Park SJ; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Noh J; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Kim TM; Department of Radiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Lee M; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Choi CH; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Chung HH; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Kim TJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Lee JW; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Kim BG; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Park NH; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Song YS; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Kim SY; Department of Radiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Park SY; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Kim HS; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea. Electronic address: .
Lee YY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea. Electronic address: .; Pokaż więcej
Źródło :: Gynecologic oncology [Gynecol Oncol] 2022 Jun; Vol. 165 (3), pp. 493-499. Date of Electronic Publication: 2022 Mar 30.
Typ publikacji :: Journal Article
MeSH Terms :: Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Carcinoma, Ovarian Epithelial/diagnostic imaging ; Carcinoma, Ovarian Epithelial/pathology ; Carcinoma, Ovarian Epithelial/surgery ; Cytoreduction Surgical Procedures/methods ; Female ; Humans ; Neoplasm Staging ; Neoplasm, Residual/pathology ; Retrospective Studies ; Tomography, X-Ray Computed
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Inferences of carboplatin response-related signature by integrating multiomics data in ovarian serous cystadenocarcinoma.
Autorzy :: Yan JQ; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Liu M; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Ma YL; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Le KD; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Dong B; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li GH; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Pokaż więcej
Źródło :: Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2022 Jun; Vol. 247 (11), pp. 910-920. Date of Electronic Publication: 2022 Mar 12.
Typ publikacji :: Journal Article
MeSH Terms :: Cystadenocarcinoma, Serous*/drug therapy
Cystadenocarcinoma, Serous*/genetics
Cystadenocarcinoma, Serous*/pathology
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/pharmacology ; Carboplatin/therapeutic use ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Drug Resistance, Neoplasm/genetics ; Female ; Humans ; Vesicular Glutamate Transport Protein 1
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Complete Laparoscopic Interval Debulking Surgery for Advanced Ovarian Cancer Achieves Similar Survival Outcomes to Open Approach: A Propensity-Matched Study.
Autorzy :: Lecointre L; Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; IHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, France.; I-Cube UMR 7357 - Laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie, Université de Strasbourg, Strasbourg, France.
Pellerin M; Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Venkatasamy A; IHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, France.; Streinth Lab (Stress Response and Innovative Therapies), Inserm UMR_S 1113 IRFAC, Interface Recherche Fondamental et Appliquée à la Cancérologie, Strasbourg, France.
Fabacher T; Department of Public Health, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Eberst L; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
Gantzer J; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
Jochum F; Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Faller É; Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Boisramé T; Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Querleu D; Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; IHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, France.; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
Akladios C; Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Pokaż więcej
Źródło :: Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2022 Jun; Vol. 35 (6), pp. 1394-1401. Date of Electronic Publication: 2022 Mar 01.
Typ publikacji :: Journal Article
MeSH Terms :: Laparoscopy*/adverse effects
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/surgery
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/pathology ; Carcinoma, Ovarian Epithelial/surgery ; Chemotherapy, Adjuvant ; Cohort Studies ; Cytoreduction Surgical Procedures/adverse effects ; Female ; Humans ; Neoplasm Staging ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis.
Autorzy :: Hillemeyer L; Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1, D11, 48149 Muenster, Germany.
Espinoza-Sanchez NA; Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1, D11, 48149 Muenster, Germany.; Department of Radiotherapy-Radiooncology, University Hospital Münster, 48149 Muenster, Germany.
Greve B; Department of Radiotherapy-Radiooncology, University Hospital Münster, 48149 Muenster, Germany.
Hassan N; Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1, D11, 48149 Muenster, Germany.; Biotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza 12613, Egypt.
Chelariu-Raicu A; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, 81377 Munich, Germany.
Kiesel L; Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1, D11, 48149 Muenster, Germany.
Götte M; Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1, D11, 48149 Muenster, Germany.; Pokaż więcej
Źródło :: International journal of molecular sciences [Int J Mol Sci] 2022 May 21; Vol. 23 (10). Date of Electronic Publication: 2022 May 21.
Typ publikacji :: Journal Article
MeSH Terms :: Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/metabolism
Syndecan-3*/genetics
Syndecan-3*/metabolism
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/metabolism ; Cell Line, Tumor ; Cisplatin/pharmacology ; Female ; Humans ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 14 14.

Tytuł :: MS: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer.
Autorzy :: Yin S; Department of Gynaecologic Oncology, Ovarian Cancer Program, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yang L; Department of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Zheng Y; Department of Gynaecologic Oncology, Ovarian Cancer Program, Zhongshan Hospital, Fudan University, Shanghai, China.
Zang R; Department of Gynaecologic Oncology, Ovarian Cancer Program, Zhongshan Hospital, Fudan University, Shanghai, China. .; Pokaż więcej
Źródło :: Journal of ovarian research [J Ovarian Res] 2022 May 10; Vol. 15 (1), pp. 56. Date of Electronic Publication: 2022 May 10.
Typ publikacji :: Journal Article
MeSH Terms :: Cystadenocarcinoma, Serous*/blood supply
Cystadenocarcinoma, Serous*/genetics
Cystadenocarcinoma, Serous*/metabolism
Ovarian Neoplasms*/blood supply
Ovarian Neoplasms*/pathology
Protein Phosphatase 2C*/genetics
Protein Phosphatase 2C*/metabolism
STAT3 Transcription Factor*/genetics
STAT3 Transcription Factor*/metabolism
Vascular Endothelial Growth Factor A*/genetics
Vascular Endothelial Growth Factor A*/metabolism
Carcinoma, Ovarian Epithelial/blood supply ; Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/metabolism ; Cell Line, Tumor ; Female ; Humans ; Neovascularization, Pathologic/genetics ; Signal Transduction
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score.
Autorzy :: Ergasti R; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.
Marchetti C; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.
Tudisco R; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.
Iervolino A; Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.
Naldini A; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Oliva R; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.
Inzani F; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Scambia G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy .; Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.
Fagotti A; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.; Pokaż więcej
Źródło :: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2022 May 03; Vol. 32 (5), pp. 639-645. Date of Electronic Publication: 2022 May 03.
Typ publikacji :: Journal Article
MeSH Terms :: Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Cytoreduction Surgical Procedures ; Female ; Humans ; Neoadjuvant Therapy ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Mitochondrial transcription factor B2 overexpression increases M2 macrophage infiltration via cytosolic mitochondrial DNA-stimulated Interleukin-6 secretion in ovarian cancer.
Autorzy :: Wu W; Department of Pathology, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Zhou S; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Liu T; Department of Pathology, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Liang D; Department of Pathology, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.; Pokaż więcej
Źródło :: Bioengineered [Bioengineered] 2022 May; Vol. 13 (5), pp. 12211-12223.
Typ publikacji :: Journal Article
MeSH Terms :: DNA, Mitochondrial*/metabolism
Interleukin-6*/metabolism
Macrophages*/metabolism
Methyltransferases*/genetics
Methyltransferases*/metabolism
Mitochondrial Proteins*/genetics
Mitochondrial Proteins*/metabolism
Ovarian Neoplasms*/metabolism
Ovarian Neoplasms*/pathology
Transcription Factors*/genetics
Transcription Factors*/metabolism
Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/pathology ; Cell Line, Tumor ; Deoxyribonuclease I/metabolism ; Female ; Humans ; Mitochondria/metabolism ; NF-kappa B/metabolism ; Toll-Like Receptor 9/metabolism ; Tumor Microenvironment/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Association between High Diffusion-Weighted Imaging-Derived Functional Tumor Burden of Peritoneal Carcinomatosis and Overall Survival in Patients with Advanced Ovarian Carcinoma.
Autorzy :: An H; Department of Diagnostic Imaging, Sun Yat-sen University Cancer Centre, Guangzhou, China.; Department of Diagnostic Radiology, University of Hong Kong, Hong Kong.
Perucho JAU; Department of Diagnostic Radiology, University of Hong Kong, Hong Kong.
Chiu KWH; Department of Diagnostic Radiology, University of Hong Kong, Hong Kong.
Hui ES; Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong.
Chu MMY; Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong.
Ngu SF; Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong.
Ngan HYS; Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong.
Lee EYP; Department of Diagnostic Radiology, University of Hong Kong, Hong Kong. .; Pokaż więcej
Źródło :: Korean journal of radiology [Korean J Radiol] 2022 May; Vol. 23 (5), pp. 539-547.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/therapy
Peritoneal Neoplasms*/diagnostic imaging
Peritoneal Neoplasms*/therapy
Aged ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/pathology ; Female ; Humans ; Middle Aged ; Prospective Studies ; Tumor Burden
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer.
Autorzy :: Tao M; Department of Gynecology and Obstetrics, Shanghai Key Laboratory of Gynecology Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Sun F; Research Center for Marine Drugs, Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Wang J; State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Professional and Technical Ser-vice Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China.
Wang Y; State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Professional and Technical Ser-vice Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China.
Zhu H; Research Center for Marine Drugs, Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Chen M; State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Professional and Technical Ser-vice Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China.
Liu L; Research Center for Marine Drugs, Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Liu L; State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Professional and Technical Ser-vice Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China. Electronic address: .
Lin H; Research Center for Marine Drugs, Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: .
Wu X; Department of Gynecology and Obstetrics, Shanghai Key Laboratory of Gynecology Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: .; Pokaż więcej
Źródło :: Pharmacological research [Pharmacol Res] 2022 May; Vol. 179, pp. 106232. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Drug Resistance, Neoplasm ; Female ; Humans ; Organoids ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis.
Autorzy :: Hermens M; Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, the Netherlands; Department of Obstetrics & Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: .
van Altena AM; Department of Obstetrics & Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
Bulten J; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
van Vliet HAAM; Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, the Netherlands; Department of Obstetrics and Gynecology, University Hospital Ghent, Ghent, Belgium.
Siebers AG; Dutch Nationwide Registry of Histopathology and Cytopathology-Pathologisch Anatomisch Landelijk Geautomatiseerd Archief (PALGA), Houten, the Netherlands.
Bekkers RLM; Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Pokaż więcej
Źródło :: Fertility and sterility [Fertil Steril] 2022 May; Vol. 117 (5), pp. 938-945. Date of Electronic Publication: 2022 Mar 14.
Typ publikacji :: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Endometriosis*/diagnosis
Endometriosis*/epidemiology
Endometriosis*/surgery
Nevus*
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/surgery
Carcinoma, Ovarian Epithelial/diagnosis ; Carcinoma, Ovarian Epithelial/epidemiology ; Carcinoma, Ovarian Epithelial/surgery ; Cohort Studies ; Female ; Humans ; Incidence ; Ovariectomy/adverse effects ; Retrospective Studies ; Salpingo-oophorectomy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Perioperative Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Using Four Different Data Collection Methods: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study.
Autorzy :: Smith S; Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB.
Lambert P; Department of Epidemiology, Cancer Care Manitoba, Winnipeg, MB; Cancer Care Manitoba Research Institute, Winnipeg, MB.
Nachtigal MW; Cancer Care Manitoba Research Institute, Winnipeg, MB; Department of Obstetrics Gynecology and Reproductive Sciences, University of Manitoba, Winnipeg, MB; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB.
Altman AD; Cancer Care Manitoba Research Institute, Winnipeg, MB; Department of Obstetrics Gynecology and Reproductive Sciences, University of Manitoba, Winnipeg, MB; Division of Gynecologic Oncology, Cancer Care Manitoba, Winnipeg, MB. Electronic address: .; Pokaż więcej
Źródło :: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [J Obstet Gynaecol Can] 2022 May; Vol. 44 (5), pp. 475-481. Date of Electronic Publication: 2021 Oct 28.
Typ publikacji :: Journal Article
MeSH Terms :: Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/surgery
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Carcinoma, Ovarian Epithelial/epidemiology ; Carcinoma, Ovarian Epithelial/surgery ; Female ; Humans ; Incidence ; Manitoba/epidemiology ; Postoperative Complications/epidemiology ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ovarian"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język